Elevance Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St · 10/18 10:14

Elevance Health (NYSE:ELV) Third Quarter 2024 Results

Key Financial Results

  • Revenue: US$45.1b (up 5.3% from 3Q 2023).
  • Net income: US$1.02b (down 21% from 3Q 2023).
  • Profit margin: 2.3% (down from 3.0% in 3Q 2023). The decrease in margin was driven by higher expenses.
  • EPS: US$4.36 (down from US$5.48 in 3Q 2023).
earnings-and-revenue-growth
NYSE:ELV Earnings and Revenue Growth October 18th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Elevance Health Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 3.7%. Earnings per share (EPS) missed analyst estimates by 53%.

Looking ahead, revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Healthcare industry in the US.

Performance of the American Healthcare industry.

The company's shares are down 9.7% from a week ago.

Risk Analysis

We should say that we've discovered 1 warning sign for Elevance Health that you should be aware of before investing here.